Ian T. Meredith

Ian T. Meredith is currently a Vice Chancellor’s Professorial Fellow at Monash University and a Non-executive Director serving on the boards of both private and public companies. He recently retired as the Executive Vice President and Global Chief Medical Officer at Boston Scientific in, Massachusetts USA – a fortune 200, global medical device and technology company of more than 40,000 employees that provides more than 17,000 advanced medical devices and technology solutions to treat over 33 million people in 130 countries every year.

At BSC, he led clinical innovation, pre-clinical science and medical affairs across the global organization and provided leadership of the company’s clinical trial and R&D strategy. He focused on driving a vision of transformative clinical science and innovative care for all patients with chronic non-communicable diseases through critical clinical input into the company’s new business development plan, M&A strategy, and Venture portfolio.

Prior to joining Boston Scientific in 2017, Ian was Professor & Director of MonashHeart, the internationally recognized cardiology service within Monash Health, a position he held for 12 years.

For over 25 years as an Australian practicing clinician, clinical trialist and interventional cardiologist, Ian mentored and fostered the career of a generation of academic and clinical cardiologists, and personally performed more than 20,000 invasive cardiac and coronary procedures. He championed new treatment paradigms into daily clinical practice and was the chief investigator or a principal investigator on more than 30 major international, multi-centre, randomized trials including many world-first-in-human studies.

He has published more than 450 peer-reviewed scientific manuscripts, delivered more than 500 invited lectures internationally and nationally and presented as the first operator on numerous live-case operation broadcasts from MonashHeart to most of the leading international clinical conferences globally.

Ian served as a board member and medical vice-president on both the Heart Foundation of Australia’s National and Victorian state boards and as a national board member of the Cardiac Society of Australia and New Zealand from 2008 until 2016. Ian was the chief medical advocate and face of the Heart Foundation’s national public education campaign on the “Warning signs of a heart attack.” He has also served on numerous professional, state, and federal government committees and advisory boards, including the Department of Human Services Cardiac Services Review and the Federal Government Department of Health & Aging Cardiac Prostheses Advisory Group.

Most notably for Monash University, Ian conceived of, and developed the concept for, the Victorian Heart Hospital in 2005. He spent the subsequent 12 years as the principal driving force and chief medical advocate for the concept as well as the design and planning of the VHH project, Australia’s first purpose built, dedicated, stand-alone, technologically advanced heart hospital.

Alongside his recent role as EVP and Global CMO for Boston Scientific, Ian served the Victorian State Government as Medtech business ambassador to North America.

In 2012 Ian received an Order of Australia (AM) in the General Division for outstanding service to medicine in the field of Cardiology as a clinician and researcher and for advisory roles with a range of public health and organizations. In 2019 he received a Doctor of Laws, Honoris Causa for outstanding service to Monash University.